Lymphadenopathy diagnostic criteria: Difference between revisions
Jump to navigation
Jump to search
Line 3: | Line 3: | ||
{{CMG}};{{AE}}{{ADS}} | {{CMG}};{{AE}}{{ADS}} | ||
==Overview== | ==Overview== | ||
Diagnostic criteria for [[malignant]] [[lymphadenopathy]], may include: size of node more than 2 cm, node that is draining, hard, or fixed to underlying tissue, atypical location (e.g. [[supraclavicular]] node), associated risk factors (e.g. [[HIV AIDS|HIV]] or [[Tuberculosis|TB]]), fever and/or weight loss, and [[splenomegaly]]. On the other hand, diagnostic criteria for [[benign]] lymphadenopathy, may include: node < 1 cm, node that is mobile, soft-or tender, and is not fixed to underlying tissue, typical location (e.g. [[supraclavicular]] node), no associated risk factors, and palpable and painful enlargement. | Diagnostic criteria for [[malignant]] [[lymphadenopathy]], may include: size of node more than 2 cm, node that is draining, hard, or fixed to underlying tissue, atypical location (e.g. [[supraclavicular]] node), associated risk factors (e.g. [[HIV AIDS|HIV]] or [[Tuberculosis|TB]]), fever and/or weight loss, and [[splenomegaly]]. On the other hand, diagnostic criteria for [[benign]] lymphadenopathy, may include: node < 1 cm, node that is mobile, soft-or tender, and is not fixed to underlying tissue, typical location (e.g. [[supraclavicular]] node), no associated risk factors, and palpable and painful enlargement. | ||
Revision as of 14:57, 8 January 2021
Lymphadenopathy Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Lymphadenopathy diagnostic criteria On the Web |
American Roentgen Ray Society Images of Lymphadenopathy diagnostic criteria |
Risk calculators and risk factors for Lymphadenopathy diagnostic criteria |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Amandeep Singh M.D.[2]
Overview
Diagnostic criteria for malignant lymphadenopathy, may include: size of node more than 2 cm, node that is draining, hard, or fixed to underlying tissue, atypical location (e.g. supraclavicular node), associated risk factors (e.g. HIV or TB), fever and/or weight loss, and splenomegaly. On the other hand, diagnostic criteria for benign lymphadenopathy, may include: node < 1 cm, node that is mobile, soft-or tender, and is not fixed to underlying tissue, typical location (e.g. supraclavicular node), no associated risk factors, and palpable and painful enlargement.
Diagnostic Criteria
Malignant Lymphadenopathy
- Node > 2 cm
- Node that is draining, hard, or fixed to underlying tissue
- Atypical location (e.g. supraclavicular node)
- Risk factors (e.g. HIV or TB)
- Fever and/or weight loss
- Splenomegaly
Benign Lymphadenopathy
- Node < 1 cm
- Node that is mobile, soft-or tender, and is not fixed to underlying tissue
- Common location (e.g. supraclavicular node)
- No associated risk factors
- Palpable and painful enlargement